Advertisement

Topics

EPA to Grant Merck’s Patent Application for CRISPR Technology

10:00 EDT 4 Aug 2017 | Bionity

image description
Merck announced the European Patent Office (EPO) has issued a “Notice of Intention to Grant” for Merck’s patent application covering the company’s CRISPR technology used in a genomic integration method for eukaryotic cells. The patent will provide Merck’s CRISPR genomic integration technology with b...

Original Article: EPA to Grant Merck’s Patent Application for CRISPR Technology

NEXT ARTICLE

More From BioPortfolio on "EPA to Grant Merck’s Patent Application for CRISPR Technology"

Quick Search
Advertisement
 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Merck and Co
Merck & Co is the 7th largest pharmaceutical company in the world based on annual sales, which reached $25,236m in 2009. They have developed 14 vaccines and over 40 prescription products in the major therapeutic areas of cardiovascular disease, respi...